Skip to main content
Premium Trial:

Request an Annual Quote

JCVI Gets $2.4M Grant to Develop Arabidopsis Data Portal

NEW YORK (GenomeWeb News) – The J. Craig Venter Institute today said that it has received $2.4 million from the National Science Foundation to fund the first phase of a planned five-year project to develop the Arabidopsis Information Portal.

The project is being led by JCVI's Christopher Town in collaboration with scientists from the Texas Advanced Computing Center and the University of Cambridge.

The AIP will host all of the data currently housed in the Arabidopsis Information Resource, funding for which expired last month. The information portal also will provide access to integration of diverse data types, including expression data, protein interaction data, and data from the 1001 Genomes Project, which is an online catalogue of Arabidopsis genetic variation.

The AIP will have a modular design, enabling community members worldwide to develop and plug in both data and analysis modules. This will allow costs to be distributed across multiple countries and funding agencies, said JCVI.

The funding announced today covers the first year of a two-year award. The project is expected to be developed over five years.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.